90 related articles for article (PubMed ID: 7543354)
1. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1995 May; 679(2):200-4. PubMed ID: 7543354
[TBL] [Abstract][Full Text] [Related]
2. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1994 Dec; 666(1):147-50. PubMed ID: 7534194
[TBL] [Abstract][Full Text] [Related]
3. Effect of no synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine.
Abekawa T; Ohmori T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):831-8. PubMed ID: 9278954
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
Ohno M; Watanabe S
Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
[TBL] [Abstract][Full Text] [Related]
5. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
Inoue H; Arai I; Shibata S; Watanabe S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain.
Abekawa T; Ohmori T; Koyama T
J Neural Transm (Vienna); 1996; 103(6):671-80. PubMed ID: 8836929
[TBL] [Abstract][Full Text] [Related]
7. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
8. Neonatal treatment with L-name (NG-nitro-L-arginine methyl ester) attenuates stereotyped behavior induced by acute methamphetamine but not development of behavioral sensitization to methamphetamine.
Semba J; Watanabe H; Suhara T; Akanuma N
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1017-23. PubMed ID: 11041541
[TBL] [Abstract][Full Text] [Related]
9. Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.
Ohmori T; Abekawa T; Koyama T
Psychopharmacology (Berl); 1995 Sep; 121(2):158-63. PubMed ID: 8545520
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine.
Stewart J; Deschamps SE; Amir S
Brain Res; 1994 Mar; 641(1):141-4. PubMed ID: 7517333
[TBL] [Abstract][Full Text] [Related]
11. L-arginine modulates morphine-induced changes in locomotion in mice.
Calignano A; Persico P; Mancuso F; Sorrentino L
Ann Ist Super Sanita; 1993; 29(3):409-12. PubMed ID: 8172459
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
13. Evidence for nitric oxide-mediated rapid locomotor effects of corticosterone in a novel environment.
Sandi C; Guaza C
Ann N Y Acad Sci; 1994 Nov; 746():398-9. PubMed ID: 7825897
[No Abstract] [Full Text] [Related]
14. Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice.
Noda Y; Yamada K; Komori Y; Sugihara H; Furukawa H; Nabeshima T
Br J Pharmacol; 1996 Apr; 117(7):1579-85. PubMed ID: 8730757
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
16. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide modulates behavioural effects elicited by substance P in rat.
Mancuso F; Calignano A; Sorrentino L
Eur J Pharmacol; 1994 Dec; 271(2-3):329-33. PubMed ID: 7535705
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats.
Sandi C; Venero C; Guaza C
Neuroendocrinology; 1996 May; 63(5):446-53. PubMed ID: 8738582
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide in experimental models of psychosis in rats.
Gupta M; Balakrishnan S; Pandhi P
Methods Find Exp Clin Pharmacol; 2001 Nov; 23(9):497-500. PubMed ID: 11876023
[TBL] [Abstract][Full Text] [Related]
20. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
